A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12)
700 patients around the world
Available in United States, Brazil, Spain
Participants eligible to enroll in the study will have participated in and completed the
relevant study requirements of the parent PAH sotatercept clinical studies.
